BUSINESS

• Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
  August 26, 2016

• Sizzling DOAC Market - 2: Makers Accumulating Data from Actual Clinical Settings to Support Proper Use
  August 25, 2016

• Announcement: Real World Data Japan 2016 to Be Held at Westin Tokyo Hotel on October 18-19
  August 25, 2016

• Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
  August 24, 2016

• Canaglu-Tenelia Combo Filed in Japan: Mitsubishi Tanabe
  August 23, 2016

• GSK Paid 6.2 Billion Yen to Doctors, Medical Institutions in 2015
  August 23, 2016

• New Treatment Options Arriving in Multiple Myeloma Arena
  August 23, 2016

• Sales per Drug Rep Check in at 168 Million Yen in FY2015: Survey
  August 22, 2016

• Oncolys to Set Up US Subsidiary to Ratchet Up Licensing Activities
  August 22, 2016

• Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
  August 22, 2016

• Oncolys, Kyoto Pref. University of Medicine to Study OBP-801 for Glaucoma
  August 19, 2016

• Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
  August 19, 2016

• CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
  August 17, 2016

• Ethical Drug Sales Down 0.8% in June: Crecon Report
  August 17, 2016

• Mitsubishi Tanabe to Focus on Sales Turnaround for Canaglu, Eyes Diabetes and Nephrology Sales of 100 Bil. Yen
  August 17, 2016

• Taiho Phama Subsidiary Gets Approval for Uzel AG
  August 16, 2016

• Japan NDA Filed for Gilead’s HIV Drug Descovy
  August 16, 2016

• Oncolys, NCC Hospital East to Run Investigator-Led Trial on Oncolytic Virus
  August 15, 2016

• AnGes MG, Vical to Form Biz Tie-Up over DNA Vaccines
  August 15, 2016

• Shionogi Begins Distribution of Ethical Isodine Products: Mundipharma
  August 15, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 449
• 450
• 451
• 452
• 453
• 454
• 455
• 456
• 457
• …
• Next ›
• 最終 »